Barinthus Biotherapeutics plc. (BRNS)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
5
$146.28M held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| MORGAN STANLEY | Aug 13, 2026 | $71.84M |
| CITADEL ADVISORS LLC | Aug 14, 2026 | $50.66M |
| RENAISSANCE TECHNOLOGIES LLC | Aug 13, 2026 | $16.50M |
| GEODE CAPITAL MANAGEMENT, LLC | May 15, 2026 | $6.62M |
| UBS Group AG | Aug 13, 2026 | $665.0K |
BRNS's filings are public. The insight is one click away.
Scrutar's AI reads every BRNS filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze BRNS filingsNo credit cardAI reports included on the free plan
Never miss a BRNS filing.
Get an email when BRNS files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.